Scholarlink

Background <p>Acute kidney injury (AKI) is a frequent and severe complication among critically ill patients. Circulating dipeptidyl peptidase 3 (cDPP3), an enzyme released upon cellular injury, has been implicated in hemodynamic instability and organ dysfunction. Its role in severe AKI remains poorly defined. We aimed to assess the prognostic significance of cDPP3 in critically ill patients with severe AKI.</p> Methods <p>In this <i>post hoc</i> analysis of the AKIKI 2 study, we included ICU patients with severe AKI (KDIGO stage 3) who were receiving (or had received) invasive mechanical ventilation and/or vasopressor support and had available blood samples at inclusion. Patients were stratified according to cDPP3 concentration using a predefined cutoff of 40 ng/mL. The primary outcome was 28-day mortality; secondary outcomes were organ support–free days.</p> Results <p>Among 287 included patients, 143 (49.8%) had cDPP3 concentrations above 40 ng/mL. High cDPP3 was associated with increased 28-day mortality (hazard ratio 1.95; 95% confidence interval 1.37–2.87, <i>p</i> &lt; 0.001). Furthermore, high cDPP3 was associated with fewer days alive without vasopressors (mean difference − 5.59; 95% CI − 8.29 to − 2.78, <i>p</i> &lt; 0.001), invasive mechanical ventilation (mean difference − 6.23; 95% CI − 8.89 to − 3.36, <i>p</i> &lt; 0.001), or renal replacement therapy (mean difference − 6.35; 95% CI − 9.14 to − 3.26, <i>p</i> &lt; 0.001). After adjustment for baseline markers of severity, both the associations with 28-day mortality and organ support-free days remained significant.</p> Conclusions <p>In critically ill patients with severe AKI, a high cDPP3 concentration at diagnosis is associated with increased short-term mortality and prolonged dependence on organ support.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prognosis of critically ill patients with severe acute kidney injury and high circulating dipeptidyl peptidase 3: a post hoc analysis of the AKIKI 2 trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月3日

查看全文
  • Adrien Picod,
  • Jeremy Boussier,
  • Sarah Tubiana,
  • Guillaume Louis,
  • Laurent Martin Lefevre,
  • Dimitri Titeca-Beauport,
  • Béatrice La Combe,
  • Sébastien Besset,
  • Julio Badie,
  • Guillaume Chevrel,
  • Nicolas Chudeau,
  • Saber Barbar,
  • Christophe Vinsonneau,
  • Jean-Marie Forel,
  • Didier Thevenin,
  • Guillaume Lacave,
  • Saad Nseir,
  • Johanna Oziel,
  • Julien Mayaux,
  • Kada Klouche,
  • Jean Reignier,
  • Jean-Damien Ricard,
  • Jean-Pierre Quenot,
  • Alexandre Mebazaa,
  • Feriel Azibani,
  • Didier Dreyfuss,
  • Stéphane Gaudry,
  • Khalil Chaïbi

摘要

Background

Acute kidney injury (AKI) is a frequent and severe complication among critically ill patients. Circulating dipeptidyl peptidase 3 (cDPP3), an enzyme released upon cellular injury, has been implicated in hemodynamic instability and organ dysfunction. Its role in severe AKI remains poorly defined. We aimed to assess the prognostic significance of cDPP3 in critically ill patients with severe AKI.

Methods

In this post hoc analysis of the AKIKI 2 study, we included ICU patients with severe AKI (KDIGO stage 3) who were receiving (or had received) invasive mechanical ventilation and/or vasopressor support and had available blood samples at inclusion. Patients were stratified according to cDPP3 concentration using a predefined cutoff of 40 ng/mL. The primary outcome was 28-day mortality; secondary outcomes were organ support–free days.

Results

Among 287 included patients, 143 (49.8%) had cDPP3 concentrations above 40 ng/mL. High cDPP3 was associated with increased 28-day mortality (hazard ratio 1.95; 95% confidence interval 1.37–2.87, p < 0.001). Furthermore, high cDPP3 was associated with fewer days alive without vasopressors (mean difference − 5.59; 95% CI − 8.29 to − 2.78, p < 0.001), invasive mechanical ventilation (mean difference − 6.23; 95% CI − 8.89 to − 3.36, p < 0.001), or renal replacement therapy (mean difference − 6.35; 95% CI − 9.14 to − 3.26, p < 0.001). After adjustment for baseline markers of severity, both the associations with 28-day mortality and organ support-free days remained significant.

Conclusions

In critically ill patients with severe AKI, a high cDPP3 concentration at diagnosis is associated with increased short-term mortality and prolonged dependence on organ support.